News
Public · Published
QDEL: China headwinds drove lower Q3 revenue and narrower FY26 guidance
QuidelOrtho reported that third-quarter revenue fell 11.6% year over year on a constant-currency basis. Adjusted EBITDA, a measure of operating earnings, was $148 million, and earnings per share were $0.31. The company narrowed its FY26 guidance as China demand remained pressured by final in-vitro diagnostic pricing guidelines.
Published:
Updated:
What happened
QuidelOrtho reported that third-quarter revenue fell 11.6% year over year on a constant-currency basis. Adjusted EBITDA, a measure of operating earnings, was $148 million, and earnings per share were $0.31. The company narrowed its FY26 guidance as China demand remained pressured by final in-vitro diagnostic pricing guidelines.
Confirmed
Global impact / market context
Lower China demand can reduce sales for diagnostic products, while final pricing guidelines may constrain what the company can charge. Together, weaker sales and pricing pressure could limit revenue growth and operating earnings, making the narrower FY26 outlook relevant to expectations for future performance.
Analyst inference
The reported revenue decline and narrowed outlook point to pressure on both current results and the company’s stated expectations for FY26. Adjusted EBITDA and earnings per share provide additional measures of the quarter, but the supplied context gives no prior-period comparisons for them.
Analyst inference
What to watch
- Watch whether China demand improves or remains pressured; continued weakness could weigh on diagnostic sales and make it harder for QuidelOrtho to meet its narrowed FY26 guidance. Analyst inference
- Watch for further detail on final in-vitro diagnostic pricing guidelines, which set prices for diagnostic tests; changes could affect the revenue QuidelOrtho earns per product sold. Analyst inference
- Compare future revenue, adjusted EBITDA, and earnings per share with this quarter’s reported figures and the narrowed FY26 outlook to assess whether operating pressure is easing. Analyst inference
Evidence
- Original source link unavailable